Bio-Techne
TECH • NASDAQ
Bio-Techne is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Shane Bohnen, with a market cap of $10.3B.
CEOShane Bohnen
Market Cap$10.3B
Biotechnology
Healthcare
Employees3.1K
Websitebio-techne.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Bio-Techne
Date
Wednesday, May 6, 2026 (in 3 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q3 2026
EPS Estimate
$0.52
Revenue Estimate
$318.2M
Earnings History
Past 12 earnings reports for Bio-Techne
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q2 2026 | $0.46Est: $0.40 | +15.0% | $295.9MEst: $291.1M | +1.6% |  10-Q |
| Nov 5, 2025 | Q1 2026 | $0.42Est: $0.40 | +5.0% | $286.6MEst: $290.5M | -1.4% | 10-Q |
| Aug 6, 2025 | Q4 2025 | $0.53Est: $0.48 | +10.4% | $317.0MEst: $315.8M | +0.4% | 10-K |
| May 7, 2025 | Q3 2025 | $0.56Est: $0.51 | +9.8% | $316.2MEst: $317.9M | -0.5% | 10-Q |
| Feb 5, 2025 | Q2 2025 | $0.42Est: $0.38 | +10.5% | $297.0MEst: $285.4M | +4.1% | 10-Q |
| Oct 30, 2024 | Q1 2025 | $0.42Est: $0.38 | +10.5% | $289.5MEst: $280.3M | +3.3% | 10-Q |
| Aug 7, 2024 | Q4 2024 | $0.49Est: $0.49 | 0.0% | $306.1MEst: $306.5M | -0.1% | 10-K |
| May 1, 2024 | Q3 2024 | $0.48Est: $0.45 | +6.7% | $303.4MEst: $292.2M | +3.8% | 10-Q |
| Feb 1, 2024 | Q2 2024 | $0.40Est: $0.41 | -2.4% | $272.6MEst: $277.5M | -1.8% | 10-Q |
| Oct 31, 2023 | Q1 2024 | $0.41Est: $0.44 | -6.8% | $276.9MEst: $287.8M | -3.8% | — |
| Aug 8, 2023 | Q4 2023 | $0.55Est: $0.55 | 0.0% | $301.3MEst: $307.3M | -1.9% | 10-K |
| May 3, 2023 | Q3 2023 | $0.53Est: $0.53 | 0.0% | $294.1MEst: $296.7M | -0.8% | — |